Trupanion (TRUP) Downgraded by ValuEngine to Hold

ValuEngine cut shares of Trupanion (NASDAQ:TRUP) from a buy rating to a hold rating in a report released on Wednesday.

Several other equities research analysts have also weighed in on TRUP. BidaskClub upgraded shares of Trupanion from a sell rating to a hold rating in a research note on Wednesday, November 7th. Canaccord Genuity reiterated a buy rating and set a $43.00 price objective on shares of Trupanion in a research note on Tuesday, November 13th. Finally, Zacks Investment Research lowered shares of Trupanion from a buy rating to a hold rating in a research note on Thursday, January 10th. Two investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The company has a consensus rating of Buy and an average price target of $44.38.

Get Trupanion alerts:

TRUP opened at $27.84 on Wednesday. The stock has a market cap of $955.83 million, a P/E ratio of -928.00 and a beta of 1.15. Trupanion has a fifty-two week low of $22.38 and a fifty-two week high of $46.70. The company has a current ratio of 1.87, a quick ratio of 1.87 and a debt-to-equity ratio of 0.10.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings data on Wednesday, February 13th. The financial services provider reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.02). The business had revenue of $82.64 million for the quarter, compared to analyst estimates of $82.16 million. Trupanion had a negative return on equity of 0.88% and a negative net margin of 0.30%. The company’s revenue for the quarter was up 24.2% compared to the same quarter last year. Sell-side analysts predict that Trupanion will post 0.11 earnings per share for the current fiscal year.

In other Trupanion news, Director Howard E. Rubin sold 60,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 14th. The shares were sold at an average price of $29.03, for a total value of $1,741,800.00. Following the sale, the director now owns 188,739 shares in the company, valued at $5,479,093.17. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Darryl Rawlings sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 6th. The shares were sold at an average price of $28.45, for a total transaction of $113,800.00. Following the completion of the sale, the chief executive officer now owns 1,551,421 shares in the company, valued at approximately $44,137,927.45. The disclosure for this sale can be found here. In the last quarter, insiders have sold 141,486 shares of company stock worth $4,108,344. 20.70% of the stock is owned by company insiders.

Large investors have recently made changes to their positions in the business. Catalyst Capital Advisors LLC acquired a new stake in shares of Trupanion in the fourth quarter valued at approximately $59,000. Citigroup Inc. increased its stake in shares of Trupanion by 12,818.2% in the fourth quarter. Citigroup Inc. now owns 2,842 shares of the financial services provider’s stock valued at $72,000 after purchasing an additional 2,820 shares during the period. Great West Life Assurance Co. Can increased its stake in shares of Trupanion by 105.1% in the fourth quarter. Great West Life Assurance Co. Can now owns 3,691 shares of the financial services provider’s stock valued at $91,000 after purchasing an additional 1,891 shares during the period. Resources Investment Advisors Inc. acquired a new stake in shares of Trupanion in the fourth quarter valued at approximately $102,000. Finally, Legal & General Group Plc increased its stake in shares of Trupanion by 14.9% in the fourth quarter. Legal & General Group Plc now owns 4,552 shares of the financial services provider’s stock valued at $116,000 after purchasing an additional 590 shares during the period. Institutional investors own 95.90% of the company’s stock.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Featured Article: Return on Investment (ROI) Defined, Explained

To view ValuEngine’s full report, visit ValuEngine’s official website.